The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has declined to approve ...

Despite the absence of pain signals, post-operative opioids control tachycardia and hypertension, highlighting the unique ...

Administration of low-dose nitroglycerin (≈60 µg/min) as an adjunct to other i.v. antihypertensive therapy may be beneficial for patients with hypertensive emergencies associated with acute ...

Key Takeaways House Bill 3749, also known as Jenifer’s Law, goes into effect on September 1, 2025, and applies only to ...

The newest trend in medical spas isn’t a facial or a massage – it’s IV therapy, used to treat anything from hangovers to acne ...

Panelists discuss how integrating subcutaneous (SubQ) therapies into oncology practice involves thorough economic evaluation, ...

It exhibits an aqueous solubility of over 300 mg per ml as its disodium salt, which allows lower dosing volumes for bolus administration as well as higher intravenous doses.

Latin America's diabetes market is set to grow at an 8% CAGR, reaching $6.33B by 2025. Driven by rising diabetes prevalence, digital health adoption, ...

Africa's diabetes market is set to grow 7.2% annually, reaching $2.73 billion by 2025. Key trends include expanding CGM access, supporting local prod ...

Although there exists a variety of electrophiles with thiol-binding properties for bioconjugation purposes (e.g., mono- and dibromomaleimides, iodoacetamides, vinyl sulfones, disulfides and ...

P267 Patient perspectives of switch in route of administration among patients established on long term intravenous infliximab therapy ...